Brightonix Imaging develops AI-powered biomedical imaging devices that enhance the accuracy of PET quantification for brain imaging without the need for MRI. Their technology addresses the challenge of precise brain diagnostics, improving patient outcomes through faster and more reliable imaging solutions.
Funding
$4.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Positron emission tomography (PET) scans for brain imaging often require a magnetic resonance imaging (MRI) scan to enhance diagnostic accuracy, adding to the cost, complexity, and duration of the imaging process. This reliance on MRI can also limit access for patients with contraindications or those in facilities lacking MRI capabilities.
Solution
Brightonix Imaging develops artificial intelligence (AI)-powered biomedical imaging solutions that improve the accuracy of PET quantification for brain imaging without requiring a separate MRI scan. Their AI algorithms analyze PET data to enhance image resolution and provide precise quantification of key biomarkers, such as amyloid plaques and dopamine transporters. This technology enables faster, more cost-effective, and more accessible brain diagnostics, potentially leading to earlier and more accurate diagnoses of neurological disorders. The company offers clinical and preclinical devices, as well as AI solutions for image analysis.
Target Audience
The primary target audience includes hospitals, imaging centers, and research institutions focused on neurological disorders, as well as pharmaceutical companies developing new treatments for these conditions.
Features
- AI-powered algorithms for enhanced PET image resolution and quantification
- MRI-free quantification of amyloid plaques for Alzheimer's disease diagnosis
- Automated analysis of dopamine transporter density for Parkinson's disease diagnosis
- Clinical PET devices for human brain imaging
- Preclinical PET devices for animal research